nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma
|
Padrnos, Leslie |
|
2018 |
18 |
10 |
p. 664-672.e2 |
artikel |
2 |
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome
|
Yalniz, Fevzi Firat |
|
2018 |
18 |
10 |
p. 658-663.e2 |
artikel |
3 |
Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi-institutional Experience and Review of the Literature
|
Broadwater, Devin R. |
|
2018 |
18 |
10 |
p. e427-e435 |
artikel |
4 |
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia
|
Kim, Hawk |
|
2018 |
18 |
10 |
p. e391-e399 |
artikel |
5 |
Corrigendum
|
|
|
2018 |
18 |
10 |
p. 692 |
artikel |
6 |
Editorial Board
|
|
|
2018 |
18 |
10 |
p. A4-A5 |
artikel |
7 |
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia
|
Bange, Erin |
|
2018 |
18 |
10 |
p. e421-e426 |
artikel |
8 |
Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
|
El-Cheikh, Jean |
|
2018 |
18 |
10 |
p. e441-e444 |
artikel |
9 |
Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non–Burkitt Aggressive B-cell Lymphoma
|
Cherng, Hua-Jay J. |
|
2018 |
18 |
10 |
p. 673-678 |
artikel |
10 |
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician
|
Hantel, Andrew |
|
2018 |
18 |
10 |
p. 636-647 |
artikel |
11 |
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
|
Mohty, Mohamad |
|
2018 |
18 |
10 |
p. e401-e419 |
artikel |
12 |
Mycophenolate Mofetil for the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma: Case Report and Review of the Literature
|
Heyman, Benjamin |
|
2018 |
18 |
10 |
p. e437-e440 |
artikel |
13 |
Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
|
Heyman, Benjamin |
|
2018 |
18 |
10 |
p. 679-686 |
artikel |
14 |
Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience
|
Apodaca, Elia |
|
2018 |
18 |
10 |
p. e373-e380 |
artikel |
15 |
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL
|
Li, Linyu |
|
2018 |
18 |
10 |
p. e381-e389 |
artikel |
16 |
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma
|
O'Brien, Susan |
|
2018 |
18 |
10 |
p. 648-657.e15 |
artikel |
17 |
SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5q
|
Talati, Chetasi |
|
2018 |
18 |
10 |
p. 629-635 |
artikel |
18 |
Table of Contents
|
|
|
2018 |
18 |
10 |
p. A11, A17-A19 |
artikel |
19 |
Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma
|
Gurion, Ronit |
|
2018 |
18 |
10 |
p. 687-691 |
artikel |